miR‐221 targets among other genes BCL2L11, which exhibits pro‐apoptotic properties, thereby suppressing tumor growth (Aichberger et al., 2009), as well as the gatekeeper PTEN (Li et al., 2016). Here, PTEN is linked to neoplasm.